Tuberculosis and Respiratory Diseases (Tuberc Respir Dis) gives priority to high-quality academic experimental or clinical research that will contribute to the development of knowledge of the etiology, diagnosis and treatment of tuberculosis and respiratory diseases. Manuscripts types include Original Articles, Reviews, Case Reports, Image of the Month, Editorial, and Letter to the Editor. Other types of manuscripts will be considered subject to review by the editorial board. The journal is issued on the last day of the month.
All work must conform to the ethical guidelines specified on Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/).

Research involving human subjects must conform to the ethical guidelines specified by the Declaration of Helsinki (http://www.bioscience.org/guides/declhels.htm). It is recommended that any research dealing with a clinical trial be registered with a primary national clinical trial registration site such as http://ncrc.cdc.go.kr/cris, or other sites accredited by the WHO or the Internation Committee of Medical Journal Editors. The relevant studies must have been approved by the Institutional Ethics Board or Institutional Review Board of each institution. It should also be noted, where applicable, that study subjects provided written informed consent. In cases of animal experimental studies, the experimental procedure must conform to the guidelines of the Institutional Ethics Board or those specified on the NIH Guide for the Care and Use of Laboratory Animals. The editorial board reserves the right to require authors to submit copies of informed consent forms and a letter of the approval signed by the Institutional Ethics Board, if applicable.
Financial and material support should be disclosed in the acknowledgements. Any outside financial support associated with the study, including stocks or consultation fees, should be disclosed on the transfer of copyright form. This form must be signed by all the authors.

In general, manuscripts containing content that was previously published in other journals will not be considered. Manuscripts may not be submitted simultaneously to any other journal. However, in cases in which manuscripts are to be submitted to other journals whose primary language and readership are different from those of the current journal, a duplicate publication might be permitted by both parties, together with suitable disclosure. This is permitted in cases which fulfill the criteria specified in Annals of Internal Medicine (Ann Intern Med 1997;126:36-47).

With regard to all matters associated with research ethics, such as ethical guidelines and plagiarism/duplicate publication/scientific misconduct, the review and processing procedures are based on 'Good Publication Practice Guidelines for Medical Journals' (http://kamje.or.kr/publishing_ethics.html) and 'Guidelines on Good Publication' (http://www.publicationethics.org.uk/guidelines).
All cover letters, checklists, manuscripts, figures and tables should be submitted through the on-line submission system (http://esubmit.lungkorea.org) of The Korean Academy of Tuberculosis and Respiratory Diseases (http://www.lungkorea.org). In general, manuscripts should be submitted by first authors, but submission by co-authors can be permitted.

The cover letter should state that the manuscript contains the authors' original work. If full or partial results described in this manuscript were previously published or reported in other journals or reports, then the authors should disclose this and provide details.

Following acceptance for publication, a copyright transfer agreement should be submitted, via fax or mail, to:

The Korean Academy of Tuberculosis and Respiratory Diseases
101-605 58, Banpo-dae, Seocho-gu, Seoul,
137-875, Korea.

Fax: 82-2-572-6683
All manuscripts submitted are reviewed and edited through the on-line submission system (http://esubmit.lungkorea.org) of The Korean Academy of Tuberculosis and Respiratory Diseases (http://www.lungkorea.org). Submission and reviewing instructions, troubleshooting and questions regarding the review process and related matters can be found on the on-line system.

Submitted manuscripts are reviewed by more than two members of the editorial board and outside specialists in the relevant fields. If the editorial board determines that a manuscript is suitable for publication, it recommends appropriate revisions and corrections to the authors. Once the authors have completed the revisions, the manuscript should be resubmitted together with a detailed letter addressing the editors' and reviewers' recommendations.

In some cases, it might be necessary to revise the style or format of a manuscript to conform to publication policy, without substantially altering the original content.

Any manuscripts that do not meet the criteria of the journal may be rejected. All decisions on publication and publication order are made by the editorial board.

During a review process, unless specific reasons are provided, failure to resubmit a revised manuscript within 90 days will be considered an abandoned publication and the review process will be concluded.

Once the proof is completed and authors are asked for final revisions, these should be submitted within a week.

Formatting

Language

Title page

Abstract

Keywords

Introduction

Materials and Methods

Results

Discussion

Acknowledgements

References

Tables

Figures

Copyright of published manuscripts is owned by Tuberculosis and Respiratory Diseases.
Publication fees are payable to the Korean Academy of Tuberculosis and Respiratory Diseases.
When additional copies are required, the number should be specified on the title page of the manuscript. There is a fee for extra copies.
Where manuscripts exceed the recommended length, a reduction in length may be required, or authors may be required to pay extra page charges.
If specialized printing methods or paper types are needed, the additional costs will be charged to the authors. This does not apply to manuscripts commissioned by the Korean Academy of Tuberculosis and Respiratory Diseases.
The Korean Academy of Tuberculosis and Respiratory Diseases
101-605 58, Banpo-dae, Seocho-gu, Seoul, 137-875, Korea

Phone : 82-2-575-3825, 576-5347
Fax : 82-2-572-6683
E-mail : katrd@lungkorea.org
Website : www.lungkorea.org